Effects of corticosteroid plus long-acting beta2-agonist on the expression of PD-L1 in double-stranded RNA-induced lung inflammation in mice

Journal of Inflammation ◽

10.1186/s12950-017-0149-4 ◽

2017 ◽

Vol 14 (1) ◽

Author(s):

Saaka Hamano ◽

Koichiro Matsumoto ◽

Ken Tonai ◽

Satoru Fukuyama ◽

Keiko Kan-o ◽

...

Keyword(s):

Lung Inflammation ◽

Double Stranded Rna ◽

Long Acting ◽

Download Full-text

Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd011594.pub2 ◽

2018 ◽

Author(s):

Han Ni ◽

Soe Moe ◽

Zay Soe ◽

Kay Thi Myint ◽

K Neelakantan Viswanathan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Aclidinium Bromide ◽

Long Acting ◽

Download Full-text

Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2016.1145659 ◽

2016 ◽

Vol 17 (5) ◽

pp. 631-642 ◽

Author(s):

Hiroshi Chantaphakul ◽

Kiat Ruxrungtham

Keyword(s):

Persistent Asthma ◽

Fixed Dose Combination ◽

Inhaled Corticosteroid ◽

Agonist Therapy ◽

Dose Combination ◽

Long Acting ◽

Download Full-text

Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

Journal of Negative Results in BioMedicine ◽

10.1186/1477-5751-13-9 ◽

2014 ◽

Vol 13 (1) ◽

Author(s):

Jan Lötvall ◽

Eric D Bateman ◽

William W Busse ◽

Paul M O’Byrne ◽

Ashley Woodcock ◽

...

Keyword(s):

Inhaled Corticosteroids ◽

Long Acting ◽

Download Full-text

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd003794.pub4 ◽

2013 ◽

Author(s):

Luis Javier Nannini ◽

Phillippa Poole ◽

Stephen J Milan ◽

Rebecca Holmes ◽

Rebecca Normansell

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Long Acting ◽

Download Full-text

Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease

10.1002/14651858.cd008532.pub2 ◽

2011 ◽

Author(s):

Charlotta Karner ◽

Christopher J Cates

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Long Acting ◽

Download Full-text

The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments

10.1183/13993003.congress-2015.pa4596 ◽

2015 ◽

Author(s):

Hirohisa Kano ◽

Akira Shiraki ◽

Joe Shindoh ◽

Morihide Ando ◽

Takashi Abe ◽

...

Keyword(s):

Exercise Tolerance ◽

Short Acting ◽

Long Acting ◽

Download Full-text

Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist

Allergy and Asthma Proceedings ◽

10.2500/aap.2016.37.3968 ◽

2016 ◽

Vol 37 (4) ◽

pp. 302-310 ◽

Author(s):

Jiangtao Lin ◽

Huaping Tang ◽

Ping Chen ◽

Haoyan Wang ◽

Mi-Kyeong Kim ◽

...

Keyword(s):

Low Dose ◽

Safety Evaluation ◽

Efficacy And Safety ◽

Inhaled Corticosteroid ◽

Fluticasone Furoate ◽

Asian Patients ◽

Long Acting ◽

Download Full-text

72 Anti-inflammatory effect of a long acting beta2-agonist (Salmeterol) and a corticosteroid (Fluticasone Propionate) on human airway epithelial cells following Staphylococcus aureus infection

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(05)80061-x ◽

2005 ◽

Vol 4 ◽

pp. S21

Keyword(s):

Staphylococcus Aureus ◽

Epithelial Cells ◽

Fluticasone Propionate ◽

Airway Epithelial Cells ◽

Airway Epithelial ◽

Aureus Infection ◽

Human Airway ◽

Long Acting ◽

Inflammatory Effect ◽

Download Full-text

Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal

Allergy and Asthma Proceedings ◽

10.2500/aap.2012.33.3512 ◽

2012 ◽

Vol 33 (2) ◽

pp. 140-144 ◽

Author(s):

Peter J. Barnes ◽

Gabriele Nicolini ◽

Andrea Bizzi ◽

Monica Spinola ◽

Dave Singh

Keyword(s):

Inhaled Corticosteroid ◽

Clinical Benefits ◽

Long Acting ◽

Download Full-text

Single inhaler triple therapy in COPD – all that glitters is not gold

Monaldi Archives for Chest Disease ◽

10.4081/monaldi.2021.1617 ◽

2021 ◽

Vol 91 (2) ◽

Author(s):

Kartik Deshmukh ◽

Arjun Khanna

Keyword(s):

Lung Function ◽

Triple Therapy ◽

Inhaled Corticosteroid ◽

Muscarinic Antagonist ◽

Exacerbation Frequency ◽

Long Acting ◽

Dear Editor, The recent studies on combination triple therapy of inhaled corticosteroid, long acting beta2 agonist and long-acting muscarinic antagonist (ICS-LABA-LAMA) in COPD have consistently demonstrated an improvement in exacerbation frequency and/or improvement of lung function...

Download Full-text